http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#Head http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion http://purl.obolibrary.org/obo/DOID_1588 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1588 http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01109 http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association http://www.w3.org/2000/01/rdf-schema#label "The use of Heparin Sodium in 0.45% Sodium Chloride Injection or Heparin Sodium in 5% Dextrose Injection is contraindicated in patients with the following conditions: History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT) [see Warnings and Precautions ( 5.3 Known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see Adverse Reactions ( 6.1 In whom suitable blood coagulation tests -- e.g., the whole blood clotting time, partial thromboplastin time, etc., -- cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin) [see Warnings and Precautions ( 5.5 An uncontrolled bleeding state [see Warnings and Precautions ( 5.2 History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT) ( 4 Known hypersensitivity to heparin or pork products ( 4 In whom suitable blood coagulation tests cannot be performed at appropriate intervals ( 4" http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB01109 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig http://purl.org/nanopub/x/hasSignature BFfWhquQcweGbbmG3CXU8oZvIQBybUOWUtk1EdkcsogC6s9C+k/IT4m/+KuuGGMX6yntISm/TM4HeF/Mq9z1j8eNiyFwgSt+4+qS0PTSd1lbl7X+yyDUFurTwqvhxKRwfCjQ3pjFBSsbIZTmGOm5XFI+m5SNYm0vPp5Jowu0GTU= http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://purl.org/dc/terms/created 2021-08-23T18:57:43.341+02:00 http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY